BioScrip Commences Patient Enrollment in Teva Neuroscience, Inc. Therapy Optimization in Multiple Sclerosis (Tops MS) Research Study
ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) announced today that Teva Neuroscience tapped BioScrip Specialty Pharmacy as one of several national research study participants in one of the most comprehensive MS research studies announced to date.